Drug and medical device clinical trials

Multicenter Phase 2 Study of Subcutaneous Isatuximab Plus Bortezomib, Lenalidomide and Dexamethasone in the Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma

This study is testing a new, easier way to give a drug called isatuximab (currently given through a drip) for people newly diagnosed with multiple myeloma who can't have a stem cell transplant. It aims to see if giving it as an injection under the skin works as well and is as safe.